Categorized | QbD News

Pharma Wastes Over $60 Billion on R&D Each Year: Outgoing EMA Chief, Thomas Lonngren

    Pharma Wastes Over $60 Billion on R&D Each Year: Outgoing EMA Chief, Thomas Lonngren

    Pharmaceutical Quality by Design received an unofficial boost in comments made by the outgoing chief of the European Medicines Agency, in an interview with The Wall Street Journal this week. He suggests that global regulatory harmonization is an “unstoppable” force.  Read on for reportage from FierceBiotech, and a link to the original source (which requires registration).

    Related posts:

    1. von Eschenbach: Why FDA Lags Behind
      Congress has starved the Agency of funding, he writes, and hampered FDA scientists from fully interacting with peers in industry...
    2. FDA Expected to Join PIC/S This Year
      The event would mark another significant step toward global regulatory harmonization and information sharing....
    3. Pharmaceutical Quality and Lessons from Toyota: Thomas Friedli on Creating a Continuous Improvement Culture in Pharma
      "You can only achieve long-term savings if you have stable running equipment that enables stable and robust processes. This is...
    4. Pharma Faces a New Year: Will it Mirror, or Break Away From, the Past?
      Effective change in the pharmaceutical industry must improve business performance, and not just a process. Ali Afnan anticipates what must...
    5. Andrew Witty on Art vs. Science in Pharma R&D
      GSK’s CEO recently wrote an interesting editorial in The Economist on the drug industry’s challenges. He criticizes the “Big R&D”...

    One Response to “Pharma Wastes Over $60 Billion on R&D Each Year: Outgoing EMA Chief, Thomas Lonngren”

    1. Pedro Hernandez says:

      Related
      Are We Running Out of Antibiotics? Newsweek, December 07, 2010
      http://www.newsweek.com/2010/12/07/are-we-running-out-of-antibiotics.html

    Trackbacks/Pingbacks


    Leave a Reply

    You must be logged in to post a comment.